FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3213106 · Received July 9, 2013

Report

Report Number
2124215-2013-09775
Event Type
Malfunction
Date Received
July 9, 2013
Date of Event
March 18, 2013
Report Date
June 3, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE LEAD REMAINS IMPLANTED AND NO OTHER ADVERSE EVENTS HAVE BEEN REPORTED. THIS PRODUCT ISSUE WILL BE UPDATED IF ADDITIONAL INFORMATION IS RECEIVED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT A LATITUDE RED ALERT WAS RECEIVED FOR THIS SYSTEM DUE TO A LOW SHOCKING IMPEDANCE MEASUREMENT. A REVIEW OF THE DAILY MEASUREMENTS CONFIRMED NORMAL MEASUREMENT IN THE 50-60 OHMS RANGE OVER THE PAST YEAR WITH ONLY ONE MEASUREMENT WHICH WAS OUT OF RANGE. THE PHYSICIAN HAS CHOSEN TO HAVE THE PATIENT WAIT FOR THEIR NORMAL FOLLOW UP. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
312181 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0158

Patients

Seq Age Sex Outcome Treatment
1 58 YR 4525| 4087| H179| H219| N164| 0158